GALMOZZI, ENRICO

GALMOZZI, ENRICO  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 39 (tempo di esecuzione: 0.012 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Hepatic fat - genetic risk score predicts hepatocellular carcinoma in HCV cirrhotic patients treated with DAAs 2020 Degasperi, ElisabettaGalmozzi, EnricoPelusi, SerenaD'Ambrosio, RobertaSoffredini, RobertaPerbellini, RiccardoFacchetti, FlorianaIavarone, MassimoValenti, LucaLampertico, Pietro + Article (author) -
TLL1 Variants do not predict hepatocellular carcinoma development in hcv cirrhotic patients treated with direct-acting antivirals 2019 Degasperi, EGalmozzi, EFarina, ELampertico, P + Article (author) -
Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistance 2018 A. LoglioF. FacchettiR.M. SoffrediniE. GalmozziP. Lampertico + Article (author) -
IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients 2018 E. GalmozziF. FacchettiA. LoglioM. Vigano'M.G. ColomboP. Lampertico + Article (author) -
Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B 2017 B. TestoniF. FacchettiE. GalmozziP. Lampertico + Article (author) -
Letter: Does the IFNL4 gene discovery really provide a causal role for the IL28B haplotype blocks? 2014 E. GalmozziP. Lampertico Article (author) -
Systematic review with meta-analysis : do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection? 2014 E. GalmozziM. ViganòP. Lampertico Article (author) -
Letter: Do interferon lambda 3 polymorphisms predict the outcome of interferon therapy in hepatitis B infection? Authors' reply 2014 E. GalmozziM. ViganòP. Lampertico Article (author) -
The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent 2014 R. D'AmbrosioA. AghemoR. De FrancescoM.G. RumiE. GalmozziS. De NicolaC. CheroniP. LamperticoM. Colombo + Article (author) -
Limited utility of ITPA deficiency to predict early anemia in HCV patients with advanced fibrosis receiving telaprevir 2014 A. AghemoGRASSI, ELEONORAM.G. RumiR. D'AmbrosioE. GalmozziE. DegasperiR. SoffrediniM. Colombo + Article (author) -
Studies of IL28B genotype and response to peginterferon in chronic hepatitis B should be stratified by HBV genotype 2013 P. LamperticoE. GalmozziM. Colombo Article (author) -
Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy 2013 A. AghemoE. DegasperiE. GalmozziM.G. RumiR. D'AmbrosioM. Colombo + Article (author) -
Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients 2013 A. AghemoE. DegasperiM.G. RumiE. GalmozziL. ValentiR. De FrancescoS. De NicolaC. CheroniM. Colombo + Article (author) -
Allelic inhibition of displacement activity : a simplified one tube allele-specific PCR for evaluation of ITPA polymorphisms 2013 E. GalmozziF. FacchettiE. DegasperiA. AghemoP. Lampertico Article (author) -
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4 2012 S. De NicolaA. AghemoM. RumiE. GalmozziL. ValentiR. SoffrediniR. De FrancescoG. PratiR. D'AmbrosioM. Colombo + Article (author) -
Genetic testing for hepatocellular carcinoma : an ambitious goal still to achieve 2012 E. GalmozziM. Colombo Article (author) -
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 2011 R. RamettaE. CanavesiM. RuscicaA.L. FracanzaniP. DongiovanniE. GalmozziP. MagniS.R. FargionL.V.C. Valenti Article (author) -
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 2011 L.V.C. ValentiR. RamettaE. CanavesiM. RuscicaA.L. FracanzaniP. DongiovanniE. GalmozziP. MagniS.R. Fargion Article (author) -
Interaction between the PNPLA3 I148M mutation, body weight, and steatosis, in determining the progression to cirrhosis in hereditary hemochromatosis 2011 L.V.C. ValentiE. GalmozziR. RamettaP. DongiovanniA.L. FracanzaniS.R. Fargion + Article (author) -
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C 2011 L.V.C. ValentiM. RumiE. GalmozziA.M. AghemoS. De NicolaP. DongiovanniA.L. FracanzaniR. RamettaM. ColomboS.R. Fargion + Article (author) -